Amdocs Statistics
Total Valuation
Amdocs has a market cap or net worth of $9.80 billion. The enterprise value is $10.24 billion.
Important Dates
The last earnings date was Tuesday, February 4, 2025, after market close.
| Earnings Date | Feb 4, 2025 |
| Ex-Dividend Date | Dec 31, 2024 |
Share Statistics
Amdocs has 112.82 million shares outstanding. The number of shares has decreased by -3.69% in one year.
| Current Share Class | 112.82M |
| Shares Outstanding | 112.82M |
| Shares Change (YoY) | -3.69% |
| Shares Change (QoQ) | -0.82% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 99.38% |
| Float | 110.63M |
Valuation Ratios
The trailing PE ratio is 20.16 and the forward PE ratio is 12.03. Amdocs's PEG ratio is 1.20.
| PE Ratio | 20.16 |
| Forward PE | 12.03 |
| PS Ratio | 2.04 |
| Forward PS | 2.14 |
| PB Ratio | 2.83 |
| P/TBV Ratio | 24.66 |
| P/FCF Ratio | 17.55 |
| P/OCF Ratio | 15.13 |
| PEG Ratio | 1.20 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 10.51, with an EV/FCF ratio of 18.34.
| EV / Earnings | 20.64 |
| EV / Sales | 2.10 |
| EV / EBITDA | 10.51 |
| EV / EBIT | 13.12 |
| EV / FCF | 18.34 |
Financial Position
The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.23.
| Current Ratio | 1.16 |
| Quick Ratio | 0.97 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 0.77 |
| Debt / FCF | 1.42 |
| Interest Coverage | 22.38 |
Financial Efficiency
Return on equity (ROE) is 14.05% and return on invested capital (ROIC) is 11.21%.
| Return on Equity (ROE) | 14.05% |
| Return on Assets (ROA) | 7.65% |
| Return on Invested Capital (ROIC) | 11.21% |
| Return on Capital Employed (ROCE) | 15.91% |
| Revenue Per Employee | $158,653 |
| Profits Per Employee | $16,171 |
| Employee Count | 30,695 |
| Asset Turnover | 0.76 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Amdocs has paid $109.49 million in taxes.
| Income Tax | 109.49M |
| Effective Tax Rate | 17.98% |
Stock Price Statistics
The stock price has decreased by -6.04% in the last 52 weeks. The beta is 0.73, so Amdocs's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -6.04% |
| 50-Day Moving Average | 85.98 |
| 200-Day Moving Average | 84.60 |
| Relative Strength Index (RSI) | 55.17 |
| Average Volume (20 Days) | 578,826 |
Short Selling Information
| Short Interest | 3.42M |
| Short Previous Month | 3.96M |
| Short % of Shares Out | 3.66% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.24 |
Income Statement
In the last 12 months, Amdocs had revenue of $4.87 billion and earned $496.37 million in profits. Earnings per share was $4.31.
| Revenue | 4.87B |
| Gross Profit | 1.75B |
| Operating Income | 780.98M |
| Pretax Income | 618.21M |
| Net Income | 496.37M |
| EBITDA | 974.60M |
| EBIT | 780.98M |
| Earnings Per Share (EPS) | $4.31 |
Full Income StatementBalance Sheet
The company has $349.01 million in cash and $793.79 million in debt, giving a net cash position of -$444.78 million or -$3.94 per share.
| Cash & Cash Equivalents | 349.01M |
| Total Debt | 793.79M |
| Net Cash | -444.78M |
| Net Cash Per Share | -$3.94 |
| Equity (Book Value) | 3.51B |
| Book Value Per Share | 30.73 |
| Working Capital | 221.90M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $647.60 million and capital expenditures -$89.11 million, giving a free cash flow of $558.49 million.
| Operating Cash Flow | 647.60M |
| Capital Expenditures | -89.11M |
| Free Cash Flow | 558.49M |
| FCF Per Share | $4.95 |
Full Cash Flow StatementMargins
Gross margin is 35.95%, with operating and profit margins of 16.04% and 10.19%.
| Gross Margin | 35.95% |
| Operating Margin | 16.04% |
| Pretax Margin | 12.50% |
| Profit Margin | 10.19% |
| EBITDA Margin | 20.01% |
| EBIT Margin | 16.04% |
| FCF Margin | 11.47% |